Grove Biopharma

Breakthrough synthetic chemistry, made in Chicago

Chicago, United States · Founded 2020 · $64.0M raised

Headquarters
Chicago
Founded
2020
Business Model
B2B
Total Funding
$64.0M
Last Round
$30.0M Series AMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Grove Biopharma is a multidisciplinary team of chemists, biologists, materials scientists, and entrepreneurs advancing a new synthetic drug modality with transformative potential for patients. Its proprietary Bionic Biologics platform integrates principles of biologic and synthetic design to target well-validated yet previously intractable disease drivers, unlocking new possibilities for therapeutic intervention. The technology was pioneered by Co-Founder Professor Nathan Gianneschi at Northwestern University, and the company is based in Chicago, Illinois.

Summary

Grove Biopharma is a Biotech company based in Chicago, United States, founded in 2020. It has raised $64.0M in total across 3 rounds, most recently a $30.0M Series A round in Mar 2026. Investors include DCVC (Data Collab), Andreessen Horowitz and InVivium Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$30.0M

Sign up to see all 3 events

Funding: Venture Round through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Grove Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/grove-biopharma"><img src="https://indexed.vc/api/badge/company/grove-biopharma" alt="Grove Biopharma on Indexed.vc" width="260" height="76" /></a>